Gainers
- Axcella Health AXLA stock rose 14.4% to $0.52 during Tuesday's after-market session. Axcella Health's trading volume hit 61.8 million shares by close, accounting for 4940.4% of its average volume over the last 100 days. The company's market cap stands at $37.9 million.
- Carmell Therapeutics CTCX stock moved upwards by 8.69% to $4.0. The market value of their outstanding shares is at $92.3 million.
- ContraFect CFRX stock moved upwards by 8.08% to $0.79. The market value of their outstanding shares is at $8.4 million.
- Infinity Pharmaceuticals INFI shares rose 7.81% to $0.09. Infinity Pharmaceuticals's trading volume hit 290.2K shares by close, accounting for 8.9% of its average volume over the last 100 days. The company's market cap stands at $7.8 million.
- Beyond Air XAIR stock rose 7.42% to $3.04. The company's market cap stands at $96.4 million.
- Healthcare Triangle HCTI stock moved upwards by 6.61% to $4.48. The company's market cap stands at $19.1 million.
Losers
- FibroGen FGEN shares declined by 18.0% to $1.05 during Tuesday's after-market session. Trading volume for this security closed at 690.6K, accounting for 20.8% of its average full-day volume over the last 100 days. The company's market cap stands at $103.1 million.
- TransCode Therapeutics RNAZ stock decreased by 12.8% to $1.5. The market value of their outstanding shares is at $3.0 million.
- Precipio PRPO stock fell 7.69% to $0.34. The market value of their outstanding shares is at $9.2 million.
- AEON Biopharma AEON stock fell 7.47% to $3.72. The company's market cap stands at $138.2 million.
- Vaccinex VCNX shares decreased by 6.83% to $0.21. The market value of their outstanding shares is at $14.6 million.
- NanoVibronix NAOV shares declined by 6.81% to $1.37. The market value of their outstanding shares is at $2.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in